Barney King work email
- Valid
Barney King personal email
Dr. King specializes in strategic product development planning & execution for pharmaceutical, biotechnology, medical device, & medical diagnostics companies and in due diligence consulting for venture capital, investment, pharmaceutical, and private equity firmsOver his professional career, Dr. King has management and hands-on experience across the full scope of clinical development functions, including: project management, clinical affairs, regulatory affairs, data management, statistics, clinical operations, medical affairs, finance, safety and pharmacovigilence, non-clinical development and discovery. Activities have spanned pre-IND programs and Phase 1 through Phase 4 trial design and execution implemented across multiple therapeutic areas and geographic regions. Responsibilities have included both in-house and outsourced development programs in at least these major therapeutic areas: cardiovascular and metabolic disease, pulmonary, gastroenterology, liver disorders, kidney and urinary tract, dermatology, hematology and coagulation disorders, oncology, infectious diseases (including hepatitis C), immunology and rheumatology, endocrinology (including diabetes), neurology (CNS and peripheral disorders, including neuropathic pain), ophthalmology.Dr. King has extensive knowledge of, and experience with, current GCPs, FDA Guidances, ICH Guidelines, & EMA Scientific Guidelines. He has RAC certification for the US and the EU and has authored and been responsible for a variety of regulatory submissions in the US, EU, Eastern Europe, Asia, India, & South Africa.Specialties include clinical trials, clinical development, pharmaceuticals, pharmaceutical development, medical device development, executive management, regulatory affairs, India, US, Europe, Eastern Europe, Asia, consultant, due diligence, CRO, leadership, management, CEO, CMO, R&D, project management, strategic planning
-
Chief Medical OfficerJuvena Therapeutics Dec 2023 - PresentPalo Alto, Ca, Us
-
ConsultantJuvena Therapeutics May 2023 - Dec 2023Palo Alto, Ca, Us
-
Board MemberJust In Time For Foster Youth May 2010 - PresentSan Diego, Ca, Us -
OwnerMacnas Consulting International 2001 - PresentPrincipal in firm specializing in strategic planning, business development, organizational development, and due diligence activities, principally for the pharmaceutical and biotechnology industries, on behalf of companies and venture capital and private equity firms. Activities for clients have ranged from general consulting to filling functional positions such as CEO (including raising capital), head of R&D, head of clinical development and regulatory affairs, and medical monitor. Multiple development plans have been prepared for clients incoroporating all aspects of development from pre-clinical activities through registration. Assignments have spanned a broad range of clinical indications, e.g., rheumatoid arthritis, metabolic diseases, oncology, cardiovascular diseases, dermatology, pulmonary disease, neurologic diseases, etc. and multiple technologies.Other services have included providing due diligence and strategic planning for companies, venture capital firms, and non-profit organizations.
-
InstructorSan Diego State University 1999 - PresentSan Diego, Ca, UsTeach course in Regulatory Affairs Masters Degree programCourse is entitled, "Issues in Clinical Trials". Course covers background and history of clinical development, planning and managing activities associated with clinical product development, ethical basis and safety of clinical trials, clinical trial design, clinical operations, regulatory affairs, regulatory strategy, and future developments in clinical development -
Director, Alumni Association Board Of DirectorsUniversity Of Notre Dame 2009 - 2012Notre Dame, In, Us -
Head, Clinical OperationsMaya Clinicals 2008 - 2010Contract clinical research and data management for clinical trials in India. Extensive experience in set-up and operations for clinical product development at Indian clinical trial sites
-
Svp, DevelopmentKemia, Inc. 2006 - 2007UsPart of senior management team. Participated in all management activities, including interaction with Board of Directors. Responsible for clinical development, clinical operations, regulatory affairs, and chemistry, manufacturing, control (CMC). During tenure, filed IMPDs in Hungary and Holland (2). Also completed individual regulatory filings in Bosnia, Serbia, Ukraine, Georgia. Completed filings to 22 individual local ethical review committees and central (national) ethical review committees in 5 countries. Initiated, conducted, and completed multi-national clinical trial in rheumatoid arthritis. Filed IND in US (Endocrinology & Metabolism) and completed filings to central IRB in US. Planned, initiated, conducted, and completed multicenter clinical trial in dyslipidemia. Extensive interactions with multiple CROs in U.S. and Europe. -
President And CeoPredict, Incorporated Feb 2000 - Jul 2001Start-up high technology company focused in area of clinical bioinformatics. Business model included deployment of software in physician practices, generation of very powerful and deep database of clinical data, application of very powerful artificial intelligence software to enable pharmaceutical companies to improve identificationof well-characterized patients for enrollment into clinical trials and, by linking clinical databases with databases in genomics, proteomics, high-throughput screening, pharmacogenomics, toxicology, etc., significantly improving the processes of drug discovery and development.Responsible for all aspects of company activity. Took company through first funding round (beyond seed investment), first pharmaceutical partnership, and deployment at first clinical sites.
-
Vice President And General ManagerParexel 1999 - 2000Durham, North Carolina, UsOne of largest contract research organization (CRO) in the world. Responsible for managing more than 200 people in San Diego office representing all disciplines in business, e.g. sales, proposal development, statistics, programming, data management, clinical operations, report writing, regulatory affairs, QC, QA, human resources, project management, IS support. Also responsible for developing and operating separate business unit (with separate P&L), based in San Diego, focused on small pharma-ceutical, medical device, biotechnology and diagnostics companies. Member of corporate executive committee.During first year organized, directed and complete facilities move, increasing space by 50%. Increased headcount in San Diego office and in Emerging Companies business unit. Revenue for Emerging Group increased by 90% for year; projection for following fiscal year was an additional 60% increase. Margins increased more than revenues during this period. -
Vp, DevelopmentTrega Biosciences 1995 - 1997Officer of the company. Active participant in all strategic and operational aspects of the company. Responsible for all research and development activities relating to biological sciences, including all aspects of in-house high-throughput screening program, combinatorial biology, in vivo pharmacology, analytical sciences, animal sciences, medical and regulatory affairs, and clinical trial management. Became President of ChromaXome at time of acquisition by Trega in August 1997. Supervised 50 scientists (10 Ph.D. and 9 M.S.). Also responsible for organizing external corporate presentations, identifying potential technologies for consideration of licensing, interacting with potential licensors, analyzing potential opportunities, presenting recommendations to senior staff and board of directors. Responsible for many direct corporate interactions for the purposes of potential partnering opportunities in Japan, Europe and United States.Active participant in preparation of S-1 and all materials for IPO and participated actively in road show Initiated and developed business discussions for partnerships and served on management committees: Ono Pharmaceuticals (potential value in excess of $25 million), Chugai Pharmaceuticals (value in excess of $3 million in cash plus significant technology access and transfer), and Northwest NeuroLogic (key receptors for screening program) With head of chemistry, very effectively integrated biological and chemical research and development groups, permitting rapid screening, interpretation of data and analoging of positive compounds
-
Sr. Vp, Research And Clinical DevelopmentAdvanced Tissue 1992 - 1994Little Rock, Arkansas, UsHired to run and develop the Research and Development and Clinical Affairs groups. Led (until transfer to Segenix unit) the Project Team for the Company's lead product, Dermagraft*. Was responsible for all research programs, including skin, cartilage, bone, liver, bone marrow, intestine, and blood vessel. Was responsible for all clinical trial activity, including interactions with contract research organizations. Was responsible for all operations in the Clinical Production Laboratory, the manufacturing facility producing clinical trial supplies. Ultimately responsible for (at peak) a department of 60 individuals (company size: 110). Participated in all Senior Management functions of the company, including strategic planning and budgeting.Responsible for all aspects of planning, formation, leadership and operation of Segenix, a company spun off from parent for the purposes of commercialization of research products in areas of liver and bone marrow tissue engineering, bioreactors, and gene therapy. Activities also included fund raising and development of corporate alliances. Supervised 13 individuals (7 Ph.D.'s). -
Vice President, Medical And Regulatory Aff. WorldwideConvatec 1989 - 1992London, England, GbInitially Medical Director, North America, then promoted to Vice President, Worldwide.Initially directed a department of 28 individuals, including nurses, Ph.D.s, secretarial, data processing and clerical personnel. Provided direct medical support for all clinical trials and supervised clinical plan development, protocol development, case report form generation, trial monitoring, analysis of data, writing of reports for all clinical trials conducted in North America. Participated in Company Level Management and Product Development Committees.As VP, consolidated all medical and regulatory resources worldwide and incorporated a data management group into a single organization and then built the organization in order to support product development, registrational activities, and sales and marketing of approved products in all markets into which ConvaTec sold (68 countries worldwide). During this period, ConvaTec sales grew from $300 million per year to $450 million annually. Was responsible for all medical activities for ConvaTec worldwide, including development of Clinical Trial programs, management of trials, and data analysis for all ConvaTec products. Was responsible for all regulatory activities for ConvaTec worldwide, including preparation of dossiers for submission to regulatory authorities and interactions with regulatory agencies.Functioned as a member of ConvaTec Management Committee, ConvaTec Product Development Committee, Patent Committee and Diversification Committee. Interacted on a regular basis with Marketing, Business Development, Research and Development, Technical Operations and Regional and Local Business units.During this period, obtained MBA from Wharton. -
Group Director, Clinical InvestigationSmithkline Beecham 1986 - 1989Brentford, Middlesex, GbServed as Medical Monitor and Project Team Leader for compound (fenoldopam, dopamine-1 agonist for congestive heart failure, severe, hypertension, and chronic renal failure) with highest priority for development at SmithKline at time. Participated in Program Development for Carvedilol (Coreg). Responsible for filing NDA and IND. Consulted on other projects in infectious diseases, pulmonary, CNS, and cardiovascular diseases.As medical monitor responsible for protocol development, data review, AE monitoring, report writing, and FDA interactions.As Chairman, Worldwide Clinical Subcommittee supervised protocol development worldwide (over 20 countries), monitored status of all studies (nearly 200), monitored and organized regulatory interactions worldwide (e.g., FDA, HPB, HHC, MHC, etc.), and was responsible for all clinical development)As Project Team Leader directed team of multiple disciplines (approximately 25 members, including preclinical and clinical areas, manufacturing regulatory and marketing groups) which was responsible for development of drug. Also directed and coordinated Phase IV and V development, Japan development and regulatory submissions. In this capacity also responsible for coordination of NDA preparation (see below) and monthly presentations to corporate senior management (CEO, COO, etc.).In the NDA project directed, monitored, and coordinated the efforts of more than 200 individuals. NDA delivered on schedule. -
Assistant Professor, PhysiologyNew York Medical College 1984 - 1989Valhalla, Ny, UsCardiovascular physiologyLaboratory with Thomas Hintze, Ph.D. -
Member, Faculty SenateNew York Medical College 1985 - 1986Valhalla, Ny, Us
-
Vice Chairman, Human Subjects CommitteeNew York Medical College 1984 - 1986Valhalla, Ny, UsParticipated in review for all clinical research projects presented to institutional review board. Served as chairman in absence of Chairman of committee. Active in all operational aspects of IRB.
-
Assistant Professor, MedicineNew York Medical College 1981 - 1986Valhalla, Ny, Us
-
Director, Cardiology Training Program, Division Of CardiologyWestchester Medical Center 1983 - 1986Valhalla, New York, Us -
Assistant AttendingWestchester Medical Center 1981 - 1986Valhalla, New York, Us
-
Assistant Director, Cardiac Catheterization LabWestchester Medical Center 1981 - 1986Valhalla, New York, UsCardiologyInterventional Cardiology
-
Attending PhysicianMedical Faculty Cardiology Associates (New York Medical College) 1981 - 1986
-
Fellow, CardiologyMount Sinai Medical Center 1979 - 1981New York, Ny, Us -
Resident, Internal MedicineRiverside Methodist Hospital 1978 - 1979
-
Clinical Instructor, PathologyThe Ohio State University Medical Center 1977 - 1979Columbus, Oh, Us -
Clinical Instructor, MedicineThe Ohio State University Medical Center 1975 - 1979Columbus, Oh, Us
-
Resident, PathologyThe Ohio State University Medical Center 1977 - 1978Columbus, Oh, Us
-
CaptainUnited States Air Force 1974 - 1977Randolph Afb, Tx, UsBased at Rickenbacker AFB (OH) -
Chief, Outpatient ClinicsUsaf Hospital Rickenbacker (Oh) Air Force Base 1975 - 1976Also worked in Psychiatry, Pediatrics, Gynecology
-
Staff PhysicianUsaf Hospital Rickenbacker (Oh) Air Force Base 1974 - 1975
-
Internship, Internal MedicineRiverside Methodist Hospital 1973 - 1974
Barney King Skills
Barney King Education Details
-
The Wharton SchoolFinance -
New York Medical CollegePublic Health (Master In Public Health Program)
-
The Ohio State University College Of MedicineMd
-
University Of Notre DameScience Pre-Professional
-
Lima Central Catholic High SchoolDiploma
Frequently Asked Questions about Barney King
What company does Barney King work for?
Barney King works for Juvena Therapeutics
What is Barney King's role at the current company?
Barney King's current role is Macnas Consulting International, Inc..
What is Barney King's email address?
Barney King's email address is ba****@****uth.org
What schools did Barney King attend?
Barney King attended The Wharton School, New York Medical College, The Ohio State University College Of Medicine, University Of Notre Dame, Lima Central Catholic High School.
What are some of Barney King's interests?
Barney King has interest in Leadership, Management, Product Development, Pharmaceutical Development, Biotechnology, Pharmaceuticals, Regulatory Affairs, Drug Development, Clinical Trials, Speaking.
What skills is Barney King known for?
Barney King has skills like Clinical Trials, Pharmaceutical Industry, Biotechnology, Clinical Development, Oncology, Medical Devices, Strategic Planning, Clinical Research, Drug Development, Fda, Cardiology, Regulatory Affairs.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial